NEW YORK (GenomeWeb News) – Lucigen today said it has been awarded a $2.8 million Small Business Innovation Research grant from the National Institutes of Health to develop a point-of-care diagnostic test for influenza.

The grant, the largest SBIR award ever received by the Middleton, Wis.-based company, will go toward the development of a molecular test for influenza A and B and respiratory syncytial virus. It will be able to test multiple RNA pathogens, Lucigen said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.